What is Pulse Biosciences Inc (PLSE) stock price today?

Pulse Biosciences Inc (PLSE) currently trades at $21.17 per share. The stock has a market capitalization of $1.48B and a P/E ratio of —x.

Is PLSE stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Pulse Biosciences Inc has a Smart Value Score of 16/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is 3/9 and Altman Z-Score is -4.95.

What is Pulse Biosciences Inc's revenue and earnings?

Pulse Biosciences Inc has trailing twelve-month (TTM) revenue of $350000.00 with profit margins of 0.00%. Earnings per share (EPS) is $-1.08.

Is Pulse Biosciences Inc financially healthy?

Pulse Biosciences Inc's Piotroski F-Score is 3/9 (weak financial health). The Altman Z-Score of -4.95 places it in the distress.

PLSE

Pulse Biosciences Inc

NASDAQ: PLSE · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES

$21.17

+4.75% today

Updated 2026-04-30

Market cap

$1.48B

P/E ratio

—

P/S ratio

4,240.58x

EPS (TTM)

$-1.08

Dividend yield

—

52W range

$13 – $26

Volume

0.3M

Market cap

$1.48B

P/E ratio

—

P/S ratio

4,240.58x

EPS (TTM)

$-1.08

Dividend yield

—

52W range

$13 – $26

Volume

0.3M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

3.3

Growth

6.5

Quality

2.5

Profitability

5.0

Valuation

C+

3/9

Piotroski F-Score

Weak

-5.0

Altman Z-Score

Distress

—

Industry rank

—

View all highly rated stocks (75+) →206 stocks currently score above 75

Price targets

Analyst target

$30.00

+41.71%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

0 Strong Buy2 Buy0 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

+ Debt/equity 0.09x — low leverage

Risks

- Piotroski 3/9 — weak financial health

- Altman Z -4.95 — distress zone

- Thin margins at 0.00%

- Negative free cash flow $-14.86M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$700000.00	$-9000.00	$0.00	$350000.00	$350000.00
Net income	$-58.95M	$-42.21M	$-53.59M	$-72.78M	$-17.43M
EPS	—	—	—	—	$-1.08
Free cash flow	$-47.41M	$-33.16M	$-36.47M	$-54.44M	$-14.86M
Profit margin	-8,421.86%	469,000.00%	—	-20,794.57%	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
PLSE	$1.48B	16	3.3	2.5	5.0	6.5	—	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$336.47B	54	5.3	5.5	7.3	4.8	+42.09%	Buy
AZN	$287.11B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Pulse Biosciences Inc trades at $21.17. Our Smart Value Score of 16/100 indicates the stock is weak. The company scores 3/9 on the Piotroski F-Score. With an Altman Z-Score of -4.95, it sits in the distress. TTM revenue stands at $350000.00.

Frequently asked questions

What is Pulse Biosciences Inc's stock price?

Pulse Biosciences Inc (PLSE) trades at $21.17.

Is Pulse Biosciences Inc overvalued?

Smart Value Score 16/100 (Grade F, Strong Sell).

What is the price target of Pulse Biosciences Inc (PLSE)?

The analyst target price is $30.00, representing +41.7% upside from the current price of $21.17.

What is Pulse Biosciences Inc's revenue?

TTM revenue is $350000.00.

Piotroski F-Score?

3/9 — weak financial health.

Altman Z-Score?

-4.95 — distress.

Company info

SectorHEALTHCARE

IndustryMEDICAL INSTRUMENTS & SUPPLIES

CountryUSA

ExchangeNASDAQ

CurrencyUSD

www.pulsebiosciences.com

Quick metrics

P/S ratio4,240.58x

ROE-74.50%

Beta1.69

50D MA$21.11

200D MA$17.11

Shares out0.07B

Float0.02B

Short ratio—

Avg volume0.3M

Performance

1 week+11.81%

1 month+26.79%

3 months+71.77%

YTD+67.52%

1 year—

3 years—

5 years—

Compare

PLSE vs LLY →PLSE vs JNJ →PLSE vs ABBV →Stock screener →